Bayer Aktiengesellschaft

USPTO Trademark & Patent Filings

Bayer Aktiengesellschaft

Trademark applications and grants for Bayer Aktiengesellschaft. Bayer Aktiengesellschaft has 1444 trademark applications. The latest application filed is for "UKINTRIQ"

Company Profile
    Company Aliases
  • BAYER AKTIENGESELLSCHAFT
  • Bayer Aktiengesellschaft,
  • aktiengesellschaft bayer
  • Bayer Aktiengesellschaft - Leverkusen DE
  • BAYER AKTIENGESELLSCHAFT - Leverkusen N/A DE

Trademarks Patents
Patent Applications
Patent ApplicationDate
SUBSTITUTED OXOPYRIDINE DERIVATIVES FOR THE TREATMENT AND/OR PROPHYLAXIS OF THROMBOTIC OR THROMBOEMBOLIC DISORDERS AND/OR THROMBOTIC OR THROMBOEMBOLIC COMPLICATIONS
20220306602 - 17/414246 HEITMEIER; Stefan ;   et al.
2022-09-29
IMPROVED ENANTIOSELECTIVE HYDROGENATION OF 4-SUBSTITUTED 1,2-DIHYDROQUINOLINES IN PRESENCE OF A CHIRAL IRIDIUM CATALYST AND AN ADDITIVE
20220306583 - 17/639266 SCHOTES; Christoph ;   et al.
2022-09-29
HIGHLY EFFECTIVE FORMULATIONS ON THE BASIS OF 2-[(2,4-DICHLORPHENYL)-METHYL]-4,4'-DIMETHYL-3-ISOXAZOLIDINONES AND PREEMERGENCE HERBICIDES
20220304305 - 17/642191 KRAUSE; Jens ;   et al.
2022-09-29
SPRAY APPLICATION DEVICE
20220304296 - 17/616133 CHAPPLE; Andrew Charles ;   et al.
2022-09-29
4H-PYRROLO[3,2-C]PYRIDIN-4-ONE COMPOUNDS
20220298157 - 17/605975 SIEGEL; Stephan ;   et al.
2022-09-22
Macrocyclic chlorine substituted indole derivatives
11,447,504 - 16/764,675 Thede , et al. September 20, 2
2022-09-20
Macrocyclic chlorine substituted indole derivatives
11,447,504 - 16/764,675 Thede , et al. September 20, 2
2022-09-20
Substituted macrocyclic indole derivatives
11,440,923 - 16/764,668 Thede , et al. September 13, 2
2022-09-13
Use of non-steroidal mineralocorticoid receptor antagonists alone or in combination for the treatment of muscular or neuromuscular diseases
11,439,628 - 17/051,923 Sandner , et al. September 13, 2
2022-09-13
Method for creating a renal injury model to screen molecules for the treatment of renal injury
11,439,713 - 16/493,613 Romoli , et al. September 13, 2
2022-09-13
Patent Grants & Applications
Trademark Applications
Mark Image

Registration | Serial
Trademark
Application Date
 UKINTRIQ
"UKINTRIQ"
98498000
UKINTRIQ
2024-04-12
 TECZUNVY
"TECZUNVY"
98498011
TECZUNVY
2024-04-12
 SUNREVLY
"SUNREVLY"
98498021
SUNREVLY
2024-04-12
 SUNVYCTI
"SUNVYCTI"
98497989
SUNVYCTI
2024-04-12
"Symbol/Image"
98485514
Symbol/Image
2024-04-05
 CHARMEL
"CHARMEL"
98484229
CHARMEL
2024-04-04
 EPIQUM
"EPIQUM"
98484736
EPIQUM
2024-04-04
 CORTENIC
"CORTENIC"
98456344
CORTENIC
2024-03-19
 YAPAZVY
"YAPAZVY"
98454886
YAPAZVY
2024-03-18
 SUNHARBO
"SUNHARBO"
98454897
SUNHARBO
2024-03-18
 ENFRIZA
"ENFRIZA"
98406513
ENFRIZA
2024-02-15
 FRIOCAPT
"FRIOCAPT"
98406584
FRIOCAPT
2024-02-15
 GLAZEBLAZE
"GLAZEBLAZE"
98406586
GLAZEBLAZE
2024-02-15
 FREEZIGO
"FREEZIGO"
98406593
FREEZIGO
2024-02-15
 MEZEVITI
"MEZEVITI"
98366448
MEZEVITI
2024-01-19
 DEKTARAV
"DEKTARAV"
98366473
DEKTARAV
2024-01-19
 MEZOTIAM
"MEZOTIAM"
98366482
MEZOTIAM
2024-01-19
 CEVEGO
"CEVEGO"
98359414
CEVEGO
2024-01-16
 ACTARGO
"ACTARGO"
98359660
ACTARGO
2024-01-16
 GME:X
"GME:X"
98338576
GME:X
2024-01-02
 YOALO
"YOALO"
98301364
YOALO
2023-12-06
 LIAPTIS
"LIAPTIS"
98292478
LIAPTIS
2023-11-30
 TIZIPA
"TIZIPA"
98292598
TIZIPA
2023-11-30
 PRIDIXOR
"PRIDIXOR"
98292481
PRIDIXOR
2023-11-30
 VELANCOR
"VELANCOR"
98292564
VELANCOR
2023-11-30
 VELNEXA
"VELNEXA"
98290642
VELNEXA
2023-11-29
 INVESST
"INVESST"
98250556
INVESST
2023-11-01
 VYNYTY
"VYNYTY"
98220688
VYNYTY
2023-10-12
 PLENEXOS
"PLENEXOS"
98100819
PLENEXOS
2023-07-25
 REATIS
"REATIS"
98089603
REATIS
2023-07-18
 IZZOP
"IZZOP"
98065176
IZZOP
2023-06-29
 ZIPARION
"ZIPARION"
97888169
ZIPARION
2023-04-14
 PRIDALON
"PRIDALON"
97888174
PRIDALON
2023-04-14
 PAZINTO
"PAZINTO"
97888182
PAZINTO
2023-04-14
 SCOPARIA
"SCOPARIA"
97876376
SCOPARIA
2023-04-06
 RE:DEVICE
"RE:DEVICE"
97871703
RE:DEVICE
2023-04-04
 SUSTEED
"SUSTEED"
97804237
SUSTEED
2023-02-21
 AUTUMN
"AUTUMN"
97773337
AUTUMN
2023-01-30
 ENYTHA
"ENYTHA"
97747023
ENYTHA
2023-01-09
 LAENKYN
"LAENKYN"
97747032
LAENKYN
2023-01-09
 AVENKEN
"AVENKEN"
97746947
AVENKEN
2023-01-09
 BIBRINA
"BIBRINA"
97747050
BIBRINA
2023-01-09
 INYERO
"INYERO"
97746961
INYERO
2023-01-09
 BALVALOR
"BALVALOR"
97747009
BALVALOR
2023-01-09
 LATYVAR
"LATYVAR"
97747016
LATYVAR
2023-01-09
 STRYAX
"STRYAX"
97720787
STRYAX
2022-12-16
 XIVANA
"XIVANA"
97717582
XIVANA
2022-12-14
 BETA TRACK
"BETA TRACK"
97662840
BETA TRACK
2022-11-04
 CHECK COLLABORATE FOR HEALTHY KIDNEYS
"CHECK COLLABORATE FOR HEALTHY KIDNEYS"
97610112
CHECK COLLABORATE FOR HEALTHY KIDNEYS
2022-09-28
"Symbol/Image"
97609083
Symbol/Image
2022-09-27
 CHECK IN TIME, PROTECT IN TIME
"CHECK IN TIME, PROTECT IN TIME"
97609316
CHECK IN TIME, PROTECT IN TIME
2022-09-27
 CAL.AI
"CAL.AI"
97574770
CAL.AI
2022-09-01
 RELOQUAVIST
"RELOQUAVIST"
97570410
RELOQUAVIST
2022-08-30
 YUQUAVIST
"YUQUAVIST"
97571451
YUQUAVIST
2022-08-30
 VIQUADVIST
"VIQUADVIST"
97570389
VIQUADVIST
2022-08-30
 YOGENVIST
"YOGENVIST"
97571471
YOGENVIST
2022-08-30
 TEGENVIST
"TEGENVIST"
97570392
TEGENVIST
2022-08-30
 YEXIVIST
"YEXIVIST"
97571484
YEXIVIST
2022-08-30
 QUATTUVIST
"QUATTUVIST"
97570398
QUATTUVIST
2022-08-30
 XAVIGAVIST
"XAVIGAVIST"
97571497
XAVIGAVIST
2022-08-30
 UQEVIST
"UQEVIST"
97570402
UQEVIST
2022-08-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed